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Screening for Critical Congenital Heart Defects
Newborn screening for critical CHDs can help identify newborns with 
these conditions and allow for timely care and treatment. CDC is working 
with partners to assess the impact and outcomes of newborn screening 
for critical CHDs. 
Understanding Critical CHDs
In the United States, about 7,200 (or about 1 out of 550) babies born every 
year have a critical CHD. Babies with a critical CHD usually need surgery or 
other procedures in the first year of life. Some babies born with a critical 
CHD appear healthy at first and may be sent home with their families 
before their heart defect is detected. These babies are at risk for having 
serious complications within the first few days or weeks of life and often 
require emergency care. 
Typically, these types of heart defects lead to low levels of oxygen in a 
newborn and may be identified using pulse oximetry screening at least 24 
hours after birth. Once identified, babies with a critical CHD can be seen by 
heart doctors (cardiologists) and can receive specialized care and treatment 
that could prevent death or disability early in life. 
The Importance of Screening for Critical CHDs
Newborn screening through pulse oximetry can improve detection of critical 
CHDs in newborn babies who may not show signs of having a critical CHD. 
Pulse oximetry screening does not replace a complete history and physical 
examination, which sometimes can detect a critical CHD before oxygen 
levels in the blood become low. CDC estimates that, each year, an additional 
1,200 newborns with a critical CHD could be identified at birth hospitals by 
screening, before they even show signs of having a critical CHD. 
It is estimated that for every 200 children with a critical CHD, at least one 
death due to an undiagnosed critical CHD could potentially be avoided if all 
hospitals screened newborn babies for critical CHDs. If doctors can confirm 
that a baby has a critical CHD, the baby will receive the care he or she needs 
in a timely manner. Researchers have found newborn screening for critical 
CHDs to be a cost effective tool, meaning that the health benefits of screening 
outweigh the costs of screening. 
Critical CHDs are listed below. Those bolded are critical CHDs that pulse 
oximetry screening is most likely to detect:
•	 Coarctation of the aorta
•	 Double-outlet right ventricle
•	 d-Transposition of the great arteries
•	 Ebstein anomaly
•	 Hypoplastic left heart syndrome
•	 Interrupted aortic arch
•	 Pulmonary atresia (with intact 
septum)
•	 Single ventricle
•	 Total anomalous pulmonary  
venous connection
•	 Tetralogy of Fallot
•	 Tricuspid atresia
•	 Truncus arteriosus
•	 About 1 in every 4 babies born 
with a heart defect has a critical 
congenital heart defect (critical CHD, 
also known as critical congenital 
heart disease). 
•	 Babies with a critical CHD are at 
increased risk for death or disability 
if their condition is not diagnosed 
soon after birth. More than 75% 
of U.S. states have statewide 
requirements for hospitals to screen 
newborns for critical CHDs. In states 
that do not have required screening, 
many hospitals within these states 
screen babies for critical CHDs. 
•	 Newborn screening for critical CHDs 
involves a simple, painless, bedside 
test called pulse oximetry in which 
sensors are placed on the baby’s 
skin. This test estimates the amount 
of oxygen in a baby’s blood. Low 
levels of oxygen in the blood can be 
a sign of a critical CHD. 
•	 Newborn screening using pulse 
oximetry can identify some infants 
with a critical CHD before they show 
signs of the condition. Timely care 
and treatment can help prevent 
death or disability early in life.
CDC’s Activities for Critical CHDs
In 2011, screening for critical CHDs was added to the Recommended 
Uniform Screening Panel for newborn screening. Since then, CDC has 
been researching how well newborn screening for critical CHDs works, the 
concerns of state and local governments involved in carrying out screening, 
the costs of screening for critical CHDs, and the health outcomes of babies 
who get screened. CDC’s tracking and research activities for critical CHD 
screening include:
•	 Looking at how different states have started screening for critical CHDs in 
their hospitals, how many babies with critical CHDs have been found, and 
problems that might impact the success of critical CHD screening
•	 Studying if critical CHD screening is good value for the money, or cost-
effective, as more states begin to screen babies for critical CHDs
•	 Learning what factors might impact whether a baby is diagnosed with a 
critical CHD before being sent home
•	 Exploring how birth defects tracking programs and newborn screening 
programs can work together to facilitate critical CHD screening in states
•	 Investigating how to leverage an electronic health record framework to 
improve reporting 
Moving Forward
Although researchers are learning more about critical CHD screening efforts, much work remains. Moving forward, 
CDC is dedicated to learning more about tracking, implementation, and research, including:
•	 Using data from screening in practice to adjust and refine the set of guidelines for screening for critical CHDs
•	 Evaluating methods to help make a diagnosis (e.g., telemedicine) for newborn nurseries with limited resources
•	 Linking critical CHD screening and birth defects tracking data to evaluate current screening methods
•	 Analyzing the impact of screening on long-term outcomes among children with critical CHDs
•	 Researching screening among certain populations (e.g., those living at higher altitudes)
•	 Tracking screening implementation across the United States 
•	 Developing critical CHD screening procedures for Neonatal Intensive Care Units
•	 Continuing to work with states that are starting critical CHD screening, including work on establishing screening 
procedures, data collection, and reporting
These activities can provide important information for our continued efforts to study the impact of critical CHD 
newborn screening across the United States.
For more information visit http://www.cdc.gov/features/congenitalheartdefects/index.html. 
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